TINA GALEY: Open Payments
NPI 1437229366 · ASTORIA, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 52 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,197
Food & beverage: $1,097Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Astellas Pharma US Inc | 2 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| ABBVIE INC. | 4 | $107 |
| Exact Sciences Corporation | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $44 |
| Organon LLC | 2 | $39 |
Products named: AIRSUPRA, CAPLYTA, The Cologuard Plus Collection Kit, QULIPTA, REXULTI, VOQUEZNA, GEMTESA, Wegovy.
Industry payments across OR — which companies pay providers there.
